A phase I/II study of MS275 in combination with 5-azacitidine in patients with recurrent advanced nonsmall cell lung cancer - Stand Up To Cancer

Blog

Posted October 14, 2019

A phase I/II study of MS275 in combination with 5-azacitidine in patients with recurrent advanced nonsmall cell lung cancer

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.